A detailed history of Jane Street Group, LLC transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 98,482 shares of GH stock, worth $3.11 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
98,482
Previous 203,976 51.72%
Holding current value
$3.11 Million
Previous $5.89 Million 61.66%
% of portfolio
0.0%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$22.3 - $36.29 $2.35 Million - $3.83 Million
-105,494 Reduced 51.72%
98,482 $2.26 Million
Q2 2024

Aug 14, 2024

SELL
$16.07 - $31.84 $85,749 - $169,898
-5,336 Reduced 2.55%
203,976 $5.89 Million
Q1 2024

May 15, 2024

BUY
$17.13 - $26.91 $469,327 - $737,280
27,398 Added 15.06%
209,312 $4.32 Million
Q4 2023

Feb 14, 2024

BUY
$21.58 - $29.5 $2.32 Million - $3.16 Million
107,279 Added 143.74%
181,914 $4.92 Million
Q3 2023

Nov 14, 2023

SELL
$25.8 - $39.97 $1.27 Million - $1.96 Million
-49,099 Reduced 39.68%
74,635 $2.21 Million
Q2 2023

Aug 14, 2023

SELL
$20.94 - $38.01 $2.57 Million - $4.66 Million
-122,518 Reduced 49.75%
123,734 $4.43 Million
Q1 2023

May 15, 2023

BUY
$22.92 - $33.76 $1.23 Million - $1.81 Million
53,742 Added 27.92%
246,252 $5.77 Million
Q4 2022

Feb 14, 2023

BUY
$25.44 - $59.78 $1.46 Million - $3.43 Million
57,345 Added 42.43%
192,510 $5.24 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $2.61 Million - $3.65 Million
59,832 Added 79.42%
135,165 $7.28 Million
Q3 2022

Nov 14, 2022

BUY
$43.66 - $61.0 $2.61 Million - $3.65 Million
59,832 Added 79.42%
135,165 $7.28 Million
Q2 2022

Aug 16, 2022

SELL
$28.82 - $77.35 $826,903 - $2.22 Million
-28,692 Reduced 27.58%
75,333 $3.04 Million
Q1 2022

May 17, 2022

BUY
$48.25 - $100.49 $4.21 Million - $8.77 Million
87,260 Added 520.49%
104,025 $6.89 Million
Q4 2021

Feb 15, 2022

BUY
$88.71 - $120.43 $1.26 Million - $1.72 Million
14,255 Added 567.93%
16,765 $1.68 Million
Q3 2021

Nov 16, 2021

SELL
$98.77 - $132.17 $7.41 Million - $9.91 Million
-74,994 Reduced 96.76%
2,510 $314,000
Q2 2021

Aug 16, 2021

BUY
$109.77 - $165.68 $5.6 Million - $8.46 Million
51,043 Added 192.9%
77,504 $9.63 Million
Q1 2021

May 18, 2021

SELL
$127.04 - $179.1 $9.34 Million - $13.2 Million
-73,509 Reduced 73.53%
26,461 $4.04 Million
Q4 2020

Feb 17, 2021

BUY
$99.96 - $135.93 $3.26 Million - $4.44 Million
32,628 Added 48.45%
99,970 $12.9 Million
Q3 2020

Nov 17, 2020

SELL
$80.32 - $111.8 $1.3 Million - $1.8 Million
-16,144 Reduced 19.34%
67,342 $7.53 Million
Q2 2020

Aug 17, 2020

BUY
$60.49 - $97.5 $3.91 Million - $6.3 Million
64,610 Added 342.29%
83,486 $6.77 Million
Q1 2020

May 15, 2020

SELL
$59.04 - $88.81 $430,460 - $647,513
-7,291 Reduced 27.86%
18,876 $1.31 Million
Q4 2019

Feb 14, 2020

BUY
$59.49 - $82.78 $1.18 Million - $1.65 Million
19,919 Added 318.81%
26,167 $2.05 Million
Q3 2019

Nov 14, 2019

SELL
$62.59 - $110.3 $385,742 - $679,778
-6,163 Reduced 49.66%
6,248 $399,000
Q2 2019

Aug 15, 2019

BUY
$63.94 - $91.11 $793,559 - $1.13 Million
12,411 New
12,411 $1.07 Million

Others Institutions Holding GH

About Guardant Health, Inc.


  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $3.23B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.